Episode
This Fortnight in Medicine XXVII
- Podcast
- Sensible Medicine
- Published
- Jun 3, 2026
- Duration seconds
- 1981
- Processing state
not_requested- Canonical source
- https://www.sensible-med.com/p/this-fortnight-in-medicine-xxvii
Actions
POST https://stenobird.com/v1/public/podcasts/sensible-medicine-5998897/episodes/this-fortnight-in-medicine-xxvii/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/sensible-medicine-5998897/this-fortnight-in-medicine-xxvii.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
Reduced Melanoma After Regular Sunscreen Use: Randomized Trial Follow-Up GLP-1 Receptor Agonists or SGLT2 Inhibitors and Nonarteritic Anterior Ischemic Optic Neuropathy * Previously discussed on Fornight XXII: Glucagon-like peptide-1 receptor agonists and risk of substance use disorders among US veterans with type 2 diabetes: cohort study This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.sensible-med.com/subscribe